HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates

Luoquan Wang, Magalis Vuolo, Mark J. Suhrland, Kathie Schlesinger

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Objective: To investigate immunohistochemical staining of hepatocyte paraffin-1 (HepPar1), α-fetoprotein (AFP), polyclonal carcinoembryonic antigen (pCEA), monoclonal CEA (mCEA), MOC-31 and CD10 for differential diagnosis of hepatocellular carcinoma (HCC) from metastatic adenocarcinoma (MA) on fine needle aspiration biopsy (FNAB). Study Design: Fifty-one archival, paraffin-embedded FNAB cell blocks, representing 18 HCCs and 33 MAs, were immunostained with antibodies for AFP CD10, pCEA, mCEA, HepPar1 and MOC-31. Results HepPar1, AFP, canalicular pCEA and CD10 were positive in 78% (14 of 18), 28% (5 of 18), 72% (13 of 18) and 35% (6 of 17) of cases of HCC, respectively. The 33 MAs were negative for immunostaining of the above antibodies except for one AFP-positive MA. Ninety-seven percent (31 of 32) of the MAs and 6% (1 of 17) of the HCCs were positive for MOC-31. Monoclonal CEA was immunoreactive on 82% (27 of 33) of the MAs and negative on all the HCCs. Conclusion: HepPar1 was the most sensitive marker for HCC, followed by canalicular staining for pCEA. For MA, MOC-31 was the most sensitive marker; mCEA was slightly less sensitive but more specific. We suggest using HepPar1, pCEA, CD10, MOC-31 and mCEA as a panel for distinguishing HCC from MA in liver FNAB.

Original languageEnglish (US)
Pages (from-to)257-262
Number of pages6
JournalActa Cytologica
Volume50
Issue number3
StatePublished - 2006

Fingerprint

Carcinoembryonic Antigen
Paraffin
Fetal Proteins
Needles
Hepatocytes
Hepatocellular Carcinoma
Adenocarcinoma
Liver
Fine Needle Biopsy
Staining and Labeling
Antibodies
Differential Diagnosis

Keywords

  • Adenocarcinoma
  • Hepatocellular carcinoma
  • Immunohistochemistry
  • Liver cancer

ASJC Scopus subject areas

  • Anatomy
  • Cell Biology
  • Histology

Cite this

HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates. / Wang, Luoquan; Vuolo, Magalis; Suhrland, Mark J.; Schlesinger, Kathie.

In: Acta Cytologica, Vol. 50, No. 3, 2006, p. 257-262.

Research output: Contribution to journalArticle

@article{d2d0f87414974f238de30993c60c9ac9,
title = "HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates",
abstract = "Objective: To investigate immunohistochemical staining of hepatocyte paraffin-1 (HepPar1), α-fetoprotein (AFP), polyclonal carcinoembryonic antigen (pCEA), monoclonal CEA (mCEA), MOC-31 and CD10 for differential diagnosis of hepatocellular carcinoma (HCC) from metastatic adenocarcinoma (MA) on fine needle aspiration biopsy (FNAB). Study Design: Fifty-one archival, paraffin-embedded FNAB cell blocks, representing 18 HCCs and 33 MAs, were immunostained with antibodies for AFP CD10, pCEA, mCEA, HepPar1 and MOC-31. Results HepPar1, AFP, canalicular pCEA and CD10 were positive in 78{\%} (14 of 18), 28{\%} (5 of 18), 72{\%} (13 of 18) and 35{\%} (6 of 17) of cases of HCC, respectively. The 33 MAs were negative for immunostaining of the above antibodies except for one AFP-positive MA. Ninety-seven percent (31 of 32) of the MAs and 6{\%} (1 of 17) of the HCCs were positive for MOC-31. Monoclonal CEA was immunoreactive on 82{\%} (27 of 33) of the MAs and negative on all the HCCs. Conclusion: HepPar1 was the most sensitive marker for HCC, followed by canalicular staining for pCEA. For MA, MOC-31 was the most sensitive marker; mCEA was slightly less sensitive but more specific. We suggest using HepPar1, pCEA, CD10, MOC-31 and mCEA as a panel for distinguishing HCC from MA in liver FNAB.",
keywords = "Adenocarcinoma, Hepatocellular carcinoma, Immunohistochemistry, Liver cancer",
author = "Luoquan Wang and Magalis Vuolo and Suhrland, {Mark J.} and Kathie Schlesinger",
year = "2006",
language = "English (US)",
volume = "50",
pages = "257--262",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "3",

}

TY - JOUR

T1 - HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates

AU - Wang, Luoquan

AU - Vuolo, Magalis

AU - Suhrland, Mark J.

AU - Schlesinger, Kathie

PY - 2006

Y1 - 2006

N2 - Objective: To investigate immunohistochemical staining of hepatocyte paraffin-1 (HepPar1), α-fetoprotein (AFP), polyclonal carcinoembryonic antigen (pCEA), monoclonal CEA (mCEA), MOC-31 and CD10 for differential diagnosis of hepatocellular carcinoma (HCC) from metastatic adenocarcinoma (MA) on fine needle aspiration biopsy (FNAB). Study Design: Fifty-one archival, paraffin-embedded FNAB cell blocks, representing 18 HCCs and 33 MAs, were immunostained with antibodies for AFP CD10, pCEA, mCEA, HepPar1 and MOC-31. Results HepPar1, AFP, canalicular pCEA and CD10 were positive in 78% (14 of 18), 28% (5 of 18), 72% (13 of 18) and 35% (6 of 17) of cases of HCC, respectively. The 33 MAs were negative for immunostaining of the above antibodies except for one AFP-positive MA. Ninety-seven percent (31 of 32) of the MAs and 6% (1 of 17) of the HCCs were positive for MOC-31. Monoclonal CEA was immunoreactive on 82% (27 of 33) of the MAs and negative on all the HCCs. Conclusion: HepPar1 was the most sensitive marker for HCC, followed by canalicular staining for pCEA. For MA, MOC-31 was the most sensitive marker; mCEA was slightly less sensitive but more specific. We suggest using HepPar1, pCEA, CD10, MOC-31 and mCEA as a panel for distinguishing HCC from MA in liver FNAB.

AB - Objective: To investigate immunohistochemical staining of hepatocyte paraffin-1 (HepPar1), α-fetoprotein (AFP), polyclonal carcinoembryonic antigen (pCEA), monoclonal CEA (mCEA), MOC-31 and CD10 for differential diagnosis of hepatocellular carcinoma (HCC) from metastatic adenocarcinoma (MA) on fine needle aspiration biopsy (FNAB). Study Design: Fifty-one archival, paraffin-embedded FNAB cell blocks, representing 18 HCCs and 33 MAs, were immunostained with antibodies for AFP CD10, pCEA, mCEA, HepPar1 and MOC-31. Results HepPar1, AFP, canalicular pCEA and CD10 were positive in 78% (14 of 18), 28% (5 of 18), 72% (13 of 18) and 35% (6 of 17) of cases of HCC, respectively. The 33 MAs were negative for immunostaining of the above antibodies except for one AFP-positive MA. Ninety-seven percent (31 of 32) of the MAs and 6% (1 of 17) of the HCCs were positive for MOC-31. Monoclonal CEA was immunoreactive on 82% (27 of 33) of the MAs and negative on all the HCCs. Conclusion: HepPar1 was the most sensitive marker for HCC, followed by canalicular staining for pCEA. For MA, MOC-31 was the most sensitive marker; mCEA was slightly less sensitive but more specific. We suggest using HepPar1, pCEA, CD10, MOC-31 and mCEA as a panel for distinguishing HCC from MA in liver FNAB.

KW - Adenocarcinoma

KW - Hepatocellular carcinoma

KW - Immunohistochemistry

KW - Liver cancer

UR - http://www.scopus.com/inward/record.url?scp=33744784568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744784568&partnerID=8YFLogxK

M3 - Article

C2 - 16780018

AN - SCOPUS:33744784568

VL - 50

SP - 257

EP - 262

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 3

ER -